Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Rhodes Jennifer J Create: Alert

All | News | Filings
Date FiledTypeDescription
03/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2021 4 Rhodes Jennifer J (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns: Sold 433 shares @ $4.4, valued at $1.9k
10/15/2021 4 Rhodes Jennifer J (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns: Sold 430 shares @ $8.65, valued at $3.7k
09/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2021 4 Rhodes Jennifer J (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns: Sold 445 shares @ $10.68, valued at $4.8k
07/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/15/2021 4 Rhodes Jennifer J (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns: Sold 431 shares @ $11.01, valued at $4.7k
06/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2021 4 Rhodes Jennifer J (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns: Sold 499 shares @ $20.45, valued at $10.2k
02/19/2021 3/A Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
02/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/21/2019 4 Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Sold 940 shares @ $5.35, valued at $5k
04/10/2019 4 Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 30,000 shares @ $0
Granted 60,000 options to buy @ $6.81, valued at $408.6k
03/21/2019 4 Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Sold 1,792 shares @ $7.99, valued at $14.3k
12/21/2018 4 Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Sold 425 shares @ $7.52, valued at $3.2k
06/22/2018 4 Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Sold 1,002 shares @ $25.48, valued at $25.5k
03/22/2018 4 Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Sold 982 shares @ $25.89, valued at $25.4k
03/09/2018 4 Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 6,250 shares @ $0
Granted 37,500 options to buy @ $25.66, valued at $962.3k
12/21/2017 4 Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Sold 440 shares @ $32.3, valued at $14.2k
06/22/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2017 4/A Rhodes Jennifer J (CBO, GC & Compliance Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
01/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
11/08/2016 4 Rhodes Jennifer J (General Counsel) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 4,687 shares @ $0
Granted 28,125 options to buy @ $14.26, valued at $401.1k
05/23/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
04/14/2016 3 Form 3 - Initial statement of beneficial ownership of securities
03/29/2013 3 Rhodes Jennifer J (GC & Chief Compliance Officer) has filed a Form 3 on MEDIVATION, INC.
03/29/2013 3 Rhodes Jennifer J (GC & Chief Compliance Officer) has filed a Form 3 on MEDIVATION, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy